US-based Medtronic Inc., (NYSE: MDT) has entered into a partnership with China’s private healthcare group Asia Pacific Medical Group (APMG) with the aim of enhancing the implementation and promotion of advanced orthopedic and extrasomatic diagnosis and treatment services in China.
Launch of AiBLE Digital Intelligence Orthopedics Integrated Solution
In a significant step forward, a treatment and diagnosis center equipped with Medtronic’s AiBLE digital intelligence orthopedics integrated solution has been inaugurated at one of APMG’s hospitals in Zhenjiang. This initiative marks a commitment to leveraging technology for improved patient care in orthopedic-related fields.
Innovative Cooperation in Orthopedic Fields
The partnership is designed to create an innovative integrated cooperation model, focusing on orthopedic areas such as spinal surgery, trauma surgery, and bone tumors. Medtronic and APMG will fully leverage synergies in expert resources to jointly build an intelligent academic platform in the field of diagnosis and treatment.
Strengthening Academic Exchanges and Enhancing Medical Capabilities
Both parties will strengthen discipline construction through academic exchanges and clinical training, thereby enhancing the disciplinary and team capabilities of medical institutions. This collaboration aims to improve the quality of medical services and make them more accessible to patients.
Exploring Financing and Payment Solutions for Innovative Therapies
In addition to enhancing medical services, Medtronic and APMG will explore one-stop financing supporting services and flexible payment solutions for innovative therapies. This effort will make high-quality medical services more accessible to a broader patient population, contributing to the advancement of healthcare in China.-Fineline Info & Tech
